Abstract
A rapidly escalating outbreak of syphilis infection has been affected men who have sex with men, particularly those with HIV-1 infection. γδ T cells are unconventional immune cells with two main subsets, Vδ1 T cells and Vδ2 T cells, which possess a combination of innate and adaptive immune features allowing them against HIV-1. However, whether syphilis infection affects the phenotype and function of γδ T cells in HIV-1-infected patients remains unclear, especially in acute HIV-1 infection (AHI). In this study, we enrolled 57 HIV-1-infected patients (24 with HIV-1 infection only and 33 coinfected with syphilis) from an acute HIV-1-infected cohort in Beijing (PRIMO). A comprehensive analysis of γδ T-cell phenotype and function was performed by flow cytometry. We found syphilis coinfection could reverse the imbalance of Vδ1/Vδ2 ratio in AHI. Syphilis infection results in decreased γδ T-cell activation in AHI, but increased γδ T-cell activation in chronic HIV-1 infection (CHI). Moreover, patients with CHI had larger numbers of IL-17-producing γδ T cells than those with AHI, regardless of syphilis status. Thus, syphilis affected the γδ T-cell immune response differently in patients depending on the stages of HIV-1 disease. In addition, the percentage of IL-17-producing γδ T cells was positively correlated with the percentage of neutrophils. These results suggest that the γδ T-cell/IL-17/neutrophil axis is involved in HIV-1 pathogenesis and disease progression. Taken together, our observations provide new insight into the roles of γδ T cells in immunopathogenesis of syphilis and HIV-1 coinfection, particularly during AHI, and our findings may be helpful for the prevention of syphilis and other sexually transmitted infections and highlight the great significance on the remedy of patients coinfected with HIV-1.
Introduction
Syphilis is a chronic bacterial infection caused by the sexually transmitted pathogen, Treponema pallidum. The incidence of syphilis has increased sharply in recent years in men who have sex with men (MSM), especially those with HIV-1 infection (1–7). Syphilis worsens disease progression in HIV-1-infected patients, as demonstrated by CD4+ T-cell depletion and increased plasma HIV-1 RNA levels (8–10). Syphilis may also increase the risk of HIV-1 infection and transmission in MSM population (11, 12). Meanwhile, HIV-1 infection may effect on the presentation, disease progression, and efficacy of treatment on syphilis (13). The host immune system plays a key role in controlling HIV-1 disease progression through host restriction factors (TRIMs, APOBEC3G, SAMHD1), cytokines (IL-6, IFN-γ, TNF-α), and chemokines (MIP-1α, MIP-1β, RANTES) (14–18). Cells producing IL-17 and IFN-γ have been implicated in inflammation and central nervous system damages (19, 20). However, the cellular immune responses elicited by HIV-1 and syphilis coinfection have not been well studied.
γδ T cells account for only a small proportion (1–10%) of T lymphocytes, but are nevertheless a critical component of the innate immune system and play important roles in the first line (21). Human γδ T cells have been defined into two main subsets, Vδ1 T cells and Vδ2 T cells. Vδ1 γδ T cells are located predominantly in the mucosae, where they recognize stress-induced molecules (such as ULBPs and MICA/B), and play a protective role. By contrast, Vδ2 γδ T cells recognize phosphoantigens (such as IPP). They account for most of the circulating γδ T cells in the bloodstream and are directed against tumors and infectious diseases. In the peripheral blood, Vδ1 T cells, also known as regulatory γδ T cells, play an immunosuppressive role, through Foxp3 expression or the secretion of cytokines, such as TGF-β and IL-10 (22). On the contrary, Vδ2 T cells mainly served as a control of antiviral immunity; cytotoxic cells kill tumor cells or pathogen-infected cells by secreting cytokines, perforin, granzyme B, or through Fas-FasL pathway; antigen presentation; or B helper T-cell function (21, 23, 24). HIV-1 infection strongly depletes the numbers of Vδ2 T cells and induces Vδ2 T-cell anergy, resulting in weaker responses to IPP stimulation (25). In our previous study, we found that γδ T cells were over-activated in HIV-1 infection and were associated with HIV-1 disease progression (26). IL-17-producing γδ T cells increased in HIV-1-infected patients with fast disease progression and were involved in HIV-1 pathogenesis (26). However, to our knowledge, there are few studies describing the antisyphilitic role of γδ T cells in HIV-1 infection. In addition, increasing IFN-γ/IL-17-producing CD8+ T cells were considered as a compensation in HIV+ individuals, but they were not sufficient to eliminate the spirochete (27). Therefore, we propose that γδ T cells involved in cell-mediated antisyphilitic response in HIV-1-infected patients. However, how the phenotype and function of γδ T cells in HIV-1-infected patients with syphilis coinfection change remains unclear, especially in acute HIV-1 infection (AHI).
In the current study, we performed a comprehensive analysis of γδ T-cell phenotype and function in patients coinfected with syphilis and HIV-1. We found that syphilis affected the phenotype and function of γδ T cells differently in HIV-1-infected patients, depending on the stages of HIV-1 disease. Our observations provide new insight into the roles of γδ T cells in immunopathogenesis of syphilis and HIV-1 coinfection. These findings suggest syphilis monitoring, follow-up, and treatment in MSM or HIV-1-positive individuals should be enhanced.
Materials and Methods
Study Subjects
Study subjects used in this study were enrolled from the Beijing PRIMO Clinical Cohort, a prospective study cohort of HIV-1-negative MSM to identify AHI at Beijing You’an Hospital, Beijing, China, since October 2006 (28). After enrollment, they were screened for plasma HIV-1 antibody, HIV-1 RNA level, clinical signs of acute infection, and syphilis status. Then they were followed up every 2 months, and HIV-1 antibody and syphilis were detected at each visit. AHI was defined as a negative or indeterminate HIV-1 antibody status but a positive HIV RNA (29). Once acute HIV-1-infected cases were identified, patients were followed up at 1, 2, 4, 8, and 12 weeks, and then every 3 months and syphilis status was monitored at each visit (Figure 1). Blood samples were collected, and peripheral blood mononuclear cells (PBMCs) and plasma were isolated and cryopreserved. Estimated date of infection was defined as the mid-point between the last HIV-1 antibody negative test and the first HIV-1 antibody positive test, or as 14 days prior to a positive RNA PCR assay on the same day as a negative HIV Enzyme Immunoassay. Patients whose infection time was longer than 180 days were defined as chronic HIV-1 infection (CHI). 26 AHI and 31 CHI patients were recruited randomly. The estimated infection date of AHI and CHI patients were 62 ± 33 and 565 ± 307 days, respectively. Early HIV-1 infection can be depicted as six discrete stages proposed by Fiebig et al. (30, 31). Stage I–II: HIV-1 RNA positive, ELISA negative with 3 patients; stage III–IV: HIV-1 RNA positive, ELISA positive, and Western blot negative or indeterminate with 4 patients; stage V–VI: HIV-1 RNA positive, ELISA positive, Western blot without/with p31 band with 19 patients. Syphilis was diagnosed on the basis of a compatible history, and the results of rapid plasma reagin (RPR) test (Shanghai Kehua Company, China) and T. pallidum particle agglutination assay (TPPA) (Fujirebio Diagnostics, Inc., Japan) (32). Based on the RPR and TPPA results, AHI and CHI patients were, divided into HIV+RPR+ group (n = 15, n = 18) and HIV+RPR− group (n = 11, n = 13), respectively. All AHI and CHI patients were ART-naïve treated. 6 patients in acute HIV+RPR+ group and 4 patients in chronic HIV+RPR+ group received benzathine benzylpenicillin treatment for syphilis before their enrollment in this study. Patients with opportunistic infections or coinfections with tuberculosis, hepatitis B virus, or hepatitis C virus were excluded. Twenty age-matched male MSM HIV-1-negative controls (HC) were included as controls. The characteristics of all subjects are described in the Table 1.
Figure 1
Table 1
| Characteristics | Healthy control | Acute HIV-1 infection | P-value | Chronic HIV-1 infection | P-value | ||
|---|---|---|---|---|---|---|---|
| RPR+ | RPR− | RPR+ | RPR− | ||||
| Cases | 20 | 15 | 11 | 18 | 13 | ||
| Chinese Han population (%) | 100 | 100 | 100 | 100 | 100 | ||
| Age (years) | 29.5 ± 7.7 | 31.5 ± 6.8 | 30.3 ± 7.5 | 0.678 | 34.6 ± 7.6 | 33.6 ± 8.8 | 0.703 |
| Infection time (day) | NA | 58.6 ± 23.8 | 66.6 ± 43.8 | 0.917 | 500.9 ± 249.4 | 655.4 ± 364.1 | 0.483 |
| CD3+ T-cell count (cells/μl) | 1751 ± 467 | 1622 ± 499 | 1545 ± 537 | 0.958 | 1801 ± 846 | 1629 ± 394 | 0.857 |
| CD4+ T-cell count (cells/μl) | 865 ± 300** | 423 ± 150 | 438 ± 144 | 0.815 | 415 ± 118 | 521 ± 143 | 0.097 |
| CD8+ T-cell count (cells/μl) | 824 ± 291 | 1173 ± 503 | 1024 ± 396 | 0.716 | 1072 ± 558 | 1070 ± 397 | 0.561 |
| CD4:CD8 ratio | 1.13 ± 0.55** | 0.38 ± 0.22 | 0.49 ± 0.23 | 0.203 | 0.37 ± 0.27 | 0.56 ± 0.32 | 0.063 |
| Plasma viral load (log10 copies/ml) | NA | 4.45 ± 0.74 | 4.66 ± 1.15 | 0.978 | 4.27 ± 0.88 | 3.86 ± 0.69 | 0.267 |
Basic characteristics of all participants enrolled in this study.
Data were presented as mean ± SD.
**P < 0.001, compared with HIV-1-infected patients.
P values were determined by Mann–Whitney test.
NA, not applicable; RPR, rapid plasma reagin.
This study and all relevant experiments have been approved by the Beijing You’an Hospital Research Ethics Committee and written informed consent was obtained from each participant according to the Declaration of Helsinki. All the participants provided written informed consent for their information, and clinical samples were stored and used for research. At enrollment, all subjects provided baseline demographic, clinical, and epidemiological information by completing a standardized questionnaire. The methods were carried out in accordance with approved guidelines and regulations.
Whole-Blood Analysis
Venous blood was collected into tubes containing EDTA as an anticoagulant. Whole blood cells analysis was performed on Uritest-3000 Fully Automated Hematology Analyzer (URIT medical electronic company, Shenzhen, China). Absolute counts of CD3+, CD4+, and CD8+ T lymphocytes were obtained as previously described (26).
Viral Load Testing
Plasma HIV-1 viral load (copies/ml) were quantified using the COBAS AmpliPrep/COBAS TaqMan 48 Analyser (Roche Diagnostic, Branchburg, NJ, USA), or by real-time PCR (Abbott, Des Plaines, IL, USA), with a detection limit of 40 copies/ml of plasma.
Serological Assays
HIV-1 infection status was determined by screening with a HIV-1/2 antigen/antibody combo enzyme immunoassay (Beijing Wantai Biological Medical Company, Beijing, China). Positive specimens were further conformed by using Western blot for HIV-1/2 (HIV Blot 2.0 MP Diagnostics, Singapore). The diagnosis of syphilis was performed with the RPR test (Shanghai Kehua Company, China) and TPPA (Fujirebio Diagnostics, Inc., Japan) (32). A seropositive result for TPPA was defined as the presence of a past or current syphilis infection, while a seropositive result for both TPPA and RPR was diagnosed as a current syphilis infection.
Antibodies
Phycoerythrin (PE)-conjugated anti-human CD38 (HIT2) monoclonal antibody (mAb), allophycocyanin (APC)-conjugated anti-human HLA-DR (L243) mAb, phycoerythrin-cyanine 7 (PE-cy7)-conjugated anti-human CD3 (HIT3a) mAb, peridinin-chlorophyll protein complex cyanine 5.5 (PerCP-cy5.5)-conjugated anti-human CD27 (O323) mAb, and APC-conjugated anti-human CD45RA (HI100) mAb were purchased from Biolegend (San Diego, CA, USA). Fluorescein isothiocyanate (FITC)-conjugated anti-human pan TCRγδ mAb, PE-conjugated anti-human pan TCRγδ (IMMU510) mAb and FITC-conjugated anti-human pan Vδ2TCR mAb (IMMU389) were purchased from Immunotech (Beckman Coulter, Fullerton, France). FITC-conjugated anti-human panVδ1TCR (TS8.2) mAb was purchased from Pierce (Rockford, IL, USA). PE-conjugated IL-17A (SCPL1362) mAb and APC-conjugated interferon-γ (IFN-γ) (B27) mAb were purchased from BD Pharmingen (San Diego, CA, USA). The isotype control mAbs were purchased from the corresponding companies.
Flow Cytometry
For surface staining, PBMCs were isolated from HC and HIV-1-infected patients with or without syphilis infection. Cells were washed with 1% bovine serum albumin in PBS and were labeled with LIVE/DEAD fixable viability stain 510 (BD Biosciences, San Jose, CA, USA), and dead cells were excluded. Then, cells labeled with specific surface antibodies: gating strategy on CD3+γδTCR+ cells, Vδ1 and Vδ2 T cells, or γδTNaive (CD27+CD45RA+), γδTCM (CD27+CD45RA−), γδTEM (CD27−CD45RA−), and γδTEMRA (CD27−CD45RA+) were displayed (Figure 2). Cytometer setup and tracking calibration particles were used to ensure that fluorescence intensity measurement was consistent in all experiments. Flow cytometry Comp-Beads kits (BD Biosciences, San Jose, CA, USA) were used for compensation. Forward angle and side scatter light gating were gated on lymphocytes and were used to exclude cell debris from the analysis. Forward height and forward area were used to exclude doublet cells. Cells were performed with a FACScan flow cytometer, as previously described (33, 34). The final analysis was performed with FlowJo software (version 7.6.2; Tree Star Inc., Ashland, OR, USA), which generated a graphical output. The strategies for the analysis of flow cytometry data are detailed in Figure 2.
Figure 2
Intracellular Staining
Peripheral blood mononuclear cells were incubated with 50 ng/ml phorbol 12-myristate-13-acetate (PMA), 1 μg/ml ionomycin, and 10 μg/ml brefeldinA (Sigma, St Louis, MO, USA) at 37°C for 6 h. Cells were collected, washed, and labeled with specific surface antibodies. Then, cells were washed, fixed, permeabilized, and incubated with IL-17 and IFN-γ mAbs. Cells were performed with a FACScan flow cytometer. Cells were first gated on 510 negative cells (live cells), then gated on CD3+γδTCR+ cells, the expression of IL-17 or IFN-γ was analyzed (Figure 2). Data were analyzed by FlowJo software, as described above.
Statistical Analysis
Data are expressed as mean ± SD. Statistical analysis was performed with GraphPad Prism software version 5.03 (GraphPad Software, San Diego, CA, USA). Statistical significance P values for differences between groups were assessed by Mann–Whitney tests and one-way ANOVA test. The statistical dependence between variables was assessed by performing Spearman’s rank correlation analysis. All tests were two-tailed, and values of P < 0.05 were considered significant.
Results
Characteristics of Participants
26 AHI, 31 CHI patients, and 20 HIV-1-negative HC were enrolled in this study (Table 1). Both AHI and CHI patients were further divided into two groups (HIV+RPR+ or HIV+RPR−) based on the syphilis status. The information of all the subjects is presented in Table 1. The age, sex, and the nationality of the HIV-1-infected patients and HC are matched. The estimated date of infection and viral load of HC are unavailable. The absolute number of CD4+ T cells and CD4/CD8 ratio in AHI and CHI patients are much lower than that in HC (P < 0.001). The absolute number of CD3+ and CD8+ T cells between HIV-1-infected patients and HC are not significant different (P > 0.05, Table 1).
Syphilis Infection Has Differential Effects on the Frequencies of γδ T-Cell Subsets in Patients with AHI
First, we investigated the effect of syphilis on the frequencies of total γδ, Vδ1, and Vδ2 T-cell in HIV-1-infected patients. The frequencies of total γδ, Vδ1, and Vδ2 T cells among three groups: HC (n = 20), HIV+RPR− (n = 24), and HIV+RPR+ (n = 33) patients were compared. As shown in Figure 3A, the frequencies of total γδ T cells were not significantly different among the three groups. The frequencies of Vδ1 T cells was significantly higher in the HIV+RPR− group than in HC, but no significant difference was found compared with HIV+RPR+ group. The frequencies of Vδ2 T cells was significantly lower in both HIV+RPR− and HIV+RPR+ groups compared with HC. However, we found no significant difference in Vδ2 T-cell frequency between HIV+RPR− and HIV+RPR+ groups (Figures 3B,C). Based on the above results, we assumed that HIV-1 infection status might affect the frequencies of total γδ, Vδ1, and Vδ2 T cells. Therefore, we split the HIV+RPR− and HIV+RPR+ groups into subgroups of patients with 26 AHI and 31 CHI patients. The frequencies of total γδ, Vδ1, and Vδ2 T cells were compared between the HIV+RPR− and HIV+RPR+ subgroups with AHI and CHI. We found no significant difference of the frequencies of total γδ T cells between HIV+RPR− and HIV+RPR+ groups for either acute or CHI (Figure 3D). The frequencies of Vδ1 T cells were significantly lower in the HIV+RPR+ group than in the HIV+RPR− group for AHI patients. By contrast, in CHI, no significant difference of the frequencies of Vδ1 T cells was found between the HIV+RPR+ and HIV+RPR− groups. Moreover, in the HIV+RPR+ group, the frequencies of Vδ1 T cells were significantly higher in CHI patients than in AHI patients (Figure 3E). Conversely, in AHI patients, the frequencies of Vδ2 T cells were significantly higher in the HIV+RPR+ group than in the HIV+RPR− group. However, no significant difference of the frequencies of Vδ2 T cells between HIV+RPR− and HIV+RPR+ groups was observed in CHI patients. Moreover, for HIV+RPR+ group, the frequencies of Vδ2 T cells in AHI patients were significantly higher than that in CHI patients (Figure 3F). Taken together, these results suggest that syphilis has differential effects on the frequencies of Vδ1 and Vδ2 T cells in patients with HIV-1 infection, depending on that this infection is acute or chronic.
Figure 3
Syphilis Affects γδ T-Cell Differentiation in Patients with AHI
Memory CD4+ T-cell depletion is a major cause of HIV-1 pathogenesis and disease progression (35, 36). Like CD4+ T cells, γδ T cells can be split into naïve and memory T-cell subsets on the basis of their surface expression of CD45RA and CD27 (37). Herein, we found that the frequencies of naïve (CD27+CD45RA+, TNaïve) γδ T cells in HIV+RPR+ group in AHI patients were significantly increased compared with HC, and HIV+RPR− patients with both acute and CHI. The frequencies of TNaïve γδ T cells in HIV+RPR+ group in CHI patients were significantly higher compared with HC, but no significant differences were shown compared with the other 3 groups (Figure 4A). In AHI patients, the frequencies of central memory (CD27+CD45RA−, TCM) γδ T cells in the HIV+RPR− group were significantly lower than that in HC and HIV+RPR+ group. In CHI patients, the frequencies of TCM γδ T cells were significantly higher than that in HIV+RPR− group in AHI patients (Figure 4B). Moreover, the frequencies of effector memory (CD27−CD45RA−, TEM) γδ T cells in the HIV+RPR− and HIV+RPR+ groups in both AHI and CHI patients were significantly lower than that in HC. However, there were no significant differences of the frequencies of TEM γδ T cells between the HIV+RPR− and HIV+RPR+ groups in both AHI and CHI patients (Figure 4C). Finally, we found the frequencies of terminally differentiated (CD27−CD45RA+, TEMRA) γδ T cells in HIV+RPR− group in AHI patients were significantly higher than that in HC and HIV+RPR+ groups in both AHI and CHI patients. There was no significant difference between the HIV+RPR− and HIV+RPR+ groups in CHI patients (Figure 4D).
Figure 4
Different γδ T-cell subsets exhibit different effector functions. CD27− Vγ9Vδ2 T cells are considered as the major producer of IL-17 (38, 39) and neutrophils can regulate IL-17 production by γδ T cells (40–42). Therefore, we analyzed the relationships between the frequencies of TNaïve, TCM, TEM, and TEMRA γδ T cells and the frequencies of neutrophils (Figure S1 in Supplementary Material). We found that the frequencies of TEM γδ T cells were positively correlated with the frequencies of neutrophils. However, no relationships were observed between the frequencies of TNaïve, TCM, and TEMRA γδ T cells and the frequencies of neutrophils (Figure S1 in Supplementary Material).
Syphilis Coinfection Effects on γδ T-Cell Activation following Different Stages of HIV-1 Infection
We have shown that γδ T cells were over-activated in HIV-1-infected patients, and associated with disease progression (26, 43). Here, we investigated the effects of syphilis on γδ T-cell activation by comparing γδ T-cell activation among HC, the HIV+RPR+ and HIV+RPR− groups in both AHI and CHI patients. Consistent with our previous results, we found that the frequencies of CD38+γδ T cells were significantly higher in both the HIV+RPR+ and HIV+RPR− groups in AHI and CHI patients, compared with HC. In AHI patients, the frequencies of CD38+γδ T cells in HIV+RPR+ group were significantly lower than that in HIV+RPR− group (Figure 5A). In addition, we found that, in AHI patients, the frequencies of HLA-DR+ γδ T cells and CD38+HLA-DR+γδ T cells were significantly lower in the HIV+RPR+ group than in the HIV+RPR− group (Figures 5B,C). By contrast, in CHI patients, the frequencies of HLA-DR+ γδ T cells and CD38+HLA-DR+γδ T cells were significantly higher in the HIV+RPR+ group than that in the HIV+RPR− group (Figures 5B,C). Moreover, the frequencies of CD38+, HLA-DR+, and CD38+HLA-DR+γδ T cells in CHI patients, both HIV+RPR+ and HIV+RPR− groups, were significantly higher than that in HIV+RPR+ group in AHI patients (Figures 5A–C). In a previous study, it was reported that neutrophils inhibited γδ T-cell activation (44), we therefore analyzed the relationship between γδ T-cell activation and the percentage of neutrophils. We found that there were no correlations between the frequencies of CD38+, HLA-DR+, and CD38+HLA-DR+ γδ T cells and the percentages of neutrophils (Figure S2 in Supplementary Material). Thus, HIV-1 infection appears to lead to γδ T-cell over-activation. However, syphilis can differentially affect γδ T-cell activation status, depending on the acute or chronic nature of the HIV-1 infection.
Figure 5
IL-17-Producing γδ T Cells Are Positively Correlated with the Percentage of Neutrophils in HIV-1-Infected Patients
Previous studies have shown that IL-17 levels in the peripheral blood or central nervous system (CFS) increase in patients with asymptomatic neurosyphilis and secondary syphilis, possibly as part of the immune response to T. palladium infection (19, 20, 27, 45). γδ T cells are a major source of IL-17, which is involved in inflammation and immune response (46, 47). Therefore, we assessed and compared the frequencies of IL-17-producing and IFN-γ-producing γδ T cells in HC, and in the HIV+RPR+ and HIV+RPR− patients with acute and CHI. We found that the frequencies of IL-17-producing γδ T cells were significantly higher in CHI patients than in HC, particularly for the HIV+RPR+ group (Figure 6A). Surprisingly, we found a significant difference in the frequencies of IL-17-producing γδ T cells between the HIV+RPR+ and HIV+RPR− groups was observed in CHI patients, but not in AHI patients. Moreover, the frequencies of IL-17-producing γδ T cells in HIV+RPR+ group in CHI patients were significantly higher than that in both HIV+RPR+ and HIV+RPR− groups in AHI patients (Figure 6A). In addition, the frequency of IFN-γ-producing γδ T cells was significantly lower in the HIV+RPR+ group in CHI patients than that in HC. The frequencies of IFN-γ-producing γδ T cells in HIV+RPR+ group in AHI patients were significantly higher than that in HIV+RPR+ group in CHI patients. However, there was no significant difference in the frequency of IFN-γ-producing γδ T cells between the HIV+RPR+ and HIV+RPR− groups in both AHI and CHI patients (Figure 6B). Thus, both IL-17 and IFN-γ may be involved in γδ T-cell-mediated immune response to syphilis, which seems to depend on HIV-1 disease stage. Recent studies have shown that neutrophils can suppress γδ T-cell activation, proliferation, and IFN-γ production (44, 48). However, Coffelt et al. reported that neutrophils promoted IL-17 production by γδ T cells, leading to tumor metastasis (49). We therefore hypothesized that the differences in γδ T-cell functions in AHI and CHI patients might be associated with neutrophils. We analyzed the relationships between IL-17- or IFN-γ-producing γδ T cells and the percentage of neutrophils. We found that the frequencies of IL-17-producing γδ T cells were positively correlated with the percentage of neutrophils (Figure 6C). However, no correlation was found between the frequencies of IFN-γ-producing γδ T cells and the percentage of neutrophils (Figure 6D). Taken together, these results suggest that syphilis may lead to the recruitment of neutrophils to local sites, where they promote the production of IL-17 by γδ T cells, leading to inflammation, immune activation, and an acceleration of HIV-1 disease progression.
Figure 6
Discussion
HIV-1 and syphilis, two sexually transmitted diseases, show rapidly increasing incidences of coinfection in MSM population (2, 11). γδ T cells, a critical component of the host immune system, play an important role in controlling HIV-1 infection. However, the effects of syphilis on γδ T-cell phenotype and function remain unclear. Herein, we examined and compared the phenotype and function of γδ T cells in the HIV+RPR+ and HIV+RPR− groups of patients with AHI and CHI separately. Consistent with previous studies (26, 50), we found that HIV-1 infection disrupted the balance of Vδ1 and Vδ2 T cells, increased the frequency of Vδ1 T cells, and decreased the frequency of Vδ2 T cells (Figures 3B,C). Interestingly, we found that syphilis corrected the imbalance of Vδ1 and Vδ2 T cells in patients with AHI, by decreasing the proportion of Vδ1 T cells and increasing that of Vδ2 T cells (Figures 3E,F). However, this effect was not observed in patients with CHI. The mechanisms by which syphilis affects the proportions of Vδ1 and Vδ2 T cells in patients with AHI are unknown, but may involve an induction of Vδ1 T-cell proliferation by T. pallidum antigens early in infection (51). In this study, we found that syphilis coinfection among HIV-1-infected patients did not affect the frequency of total γδ T cells; this may due to the mutual compensation of Vδ1 and Vδ2 T cells. The frequencies of Vδ2 T cells in healthy controls are diffusion, which appeared to be donor dependent. Vδ1 and Vδ2 T cells exhibit different features in location site, cytokine secretion, and cytotoxicity (24, 46, 52, 53). Therefore, it would be more helpful to understand the mechanisms of how syphilis differentially regulates the phenotype and function of γδ T cells by analyzing the phenotypes and functions of Vδ1 and Vδ2 T cells separately in the further studies.
γδ T cells can be classified into TNaïve, TCM, TEM, and TEMRA four functional subsets. TNaïve and TCM γδ T cells are located in lymph nodes and short of immediate effector function, whereras TEM and TEMRA γδ T cells prefer to locate in inflammatory sites and show immediate effector functions (54). We found that the frequencies of TNaïve and TCM γδ T cells were significantly higher, but the frequencies of TEM and TEMRA γδ T cells were significantly lower in HIV+RPR+ group than those in HIV+RPR− group in patients with acute HIV-1-infected patients (Figure 4). These results suggest that T. pallidum may trigger γδ T-cell proliferation and differentiation, in a manner dependent on the HIV-1 stage in coinfected patients, and that the changes of the frequencies of TNaïve, TCM, TEM, and TEMRA γδ T cells may be associated with γδ T-cell activation (26). Furthermore, we observed a positive correlation between the frequencies of TEM γδ T cells and the percentage of neutrophils in AHI. This may indicate that mutual interactions between immune cells may also have some effects on γδ T-cell differentiation.
Chronic immune activation is a key hallmark of HIV-1 infection and pathogenesis (55). We found here that γδ T cells are activated in all patients with both AHI and CHI, regardless of syphilis (Figure 5). However, syphilis infection regulates γδ T-cell activation status following the different stage of HIV-1 infection, that is, the frequencies of CD38+, HLA-DR+, and CD38+HLA-DR+ γδ T cells were decreased in patients with AHI but they were increased in patients with CHI (Figure 5). These differential effects may be mediated by the spirochetal lipoproteins, abundant membrane proteins inducing a strong immune response. Moreover, these lipoproteins, which enable the spirochetes to adhere to the host, determine the interaction between the spirochetes and the host environment and immune system (56). It has been suggested that spirochetal membrane lipoproteins bear pathogen-associated molecular patterns that bind to pattern recognition receptors such as Toll-like receptors (TLRs). Spirochetal lipoproteins (T. pallidum lipoproteins) are therefore pro-inflammatory. They may activate monocytes by binding to CD14, or macrophages through a TLR-dependent pathway, leading to the production of pro-inflammatory cytokines (57–60), which drive inflammation and induce γδ T-cell activation in patients with syphilis. The fact that syphilis differentially modulates γδ T-cell activation may be ascribed to the different host immune environments exhibited in patients with AHI and CHI. Moreover, interactions among immune cells may affect γδ T-cell activation (61). However, we did not observe any correlation between γδ T-cell activation and neutrophils in AHI. The precise mechanisms by which syphilis differentially modulates γδ T-cell activation are not fully understood and deserve further investigation.
IL-17, an inflammatory cytokine, has two principal effects: host protection and immunopathogenesis, with high levels leading to cancer progression and autoimmune diseases (62). Plasma IL-17 concentration increases in secondary syphilis, possibly as part of the immune response (20, 45). Syphilis also affects the liver, where it may cause syphilitic hepatitis or hepatic inflammatory tumors in HIV-1-positive MSM (63). However, the role of IL-17 and IL-17-producing γδ T cells in HIV-1-infected patients with syphilis remains unclear. In this study, we found that patients with CHI, particularly for the HIV+RPR+ group have an increase in the proportion of IL-17-producing γδ T cells, which was positively correlated with the percentage of neutrophils (Figures 6A,C). Our findings suggest that the immune response to T. pallidum promotes the production of IL-17 by γδ T cells in patients with CHI, leading to the recruitment of neutrophils to the inflammatory site, and to mediate the immune response (44, 63, 64). We previously showed that the frequency of IL-17-producing γδ T cells was correlated with γδ T-cell activation (26). We also show here that change of activated γδ T cells has a similar trend with the frequency of IL-17-producing γδ T cells in all patients (Figures 5 and 6). Together, these findings suggest that syphilis induces the production of IL-17 by γδ T cells, thereby promoting neutrophil-mediated immunity, triggering γδ T-cell immune activation, and accelerating HIV-1 disease progression. Neutrophils have recently been recognized as a source of IL-17 (40). However, the effects of neutrophils on γδ T cells remain unclear. Further studies on the γδ T-cell/IL-17/neutrophil axis are therefore required to elucidate the mechanisms of γδ T-cell action in HIV-1 pathogenesis and HIV-1 disease progression.
In summary, syphilis infection decreases immune activation and the secretion of inflammatory cytokines in AHI. To our knowledge, it’s the first time to reveal the role of γδ T cells in HIV-1 and syphilis coinfection. However, it remains unclear why and how syphilis differentially regulates the γδ T-cell immune response at different stages of HIV-1 infection. The different effects of syphilis on γδ T cells may relate to the different host immune environments in AHI and CHI and the natural features of γδ T cells which respond in the early stages of infection. Moreover, younger age other than CD4+ T-cell, nadir CD4+ T-cell, or CD8+ T-cell counts may be one of the key factors that affect the phenotype and function of γδ T cells (65). Therefore, syphilis should be followed up, monitored, and treated in the MSM population and in patients with AHI. In addition, there are still some limitations in this study. First, the sample size is small that may cause experimental deviation; second, we did not take into consideration other pathogens in this study, such as human cytomegalovirus and Candida albicans infection, which also have some effects on γδ T cells (66–69), although the medians of CD4 T-cell count among HIV-1-infected patients more than 400 cells/μl (Table 1). Therefore, larger samples and more detailed studies in further investigation are required to address these issues in depth. Our observations provide new insight into the roles of γδ T cells in immunopathogenesis of syphilis and HIV coinfection, particularly during AHI. Our findings may be helpful for the prevention of syphilis and other sexually transmitted infections, which is just the dedication in this research and highlights the great significance on the remedy of patients coinfected with HIV.
Statements
Ethics statement
This study and all relevant experiments have been approved by the Beijing You’an Hospital Research Ethics Committee and written informed consent was obtained from each participant according to the declaration of Helsinki. All the participants provided written informed consent for their information, and clinical samples were stored and used for research. At enrollment, all subjects provided baseline demographic, clinical and epidemiological information by completing a standardized questionnaire. The methods were carried out in accordance with approved guidelines and regulations.
Author contributions
ZL, HW, BS, and TZ conceived and designed the experiments; QZ, AS, YG, JY, and XH collected the sample information, contributed to reagents and materials; ZL, XL, ZH, ZWL, AS and DM performed the experiments and analyzed the data; and ZL, BS, WJ, HW, and TZ wrote the manuscript. All authors read and approved the final manuscript.
Funding
This work was supported by the National Natural Science Foundation of China (81501731, 81501732, 81571973), the Beijing Municipal of Science and Technology Major Project (D141100000314005, D141100000314002, D161100000416003), the Funding for Chinese overseas talents returning to China in 2016 (BS), the Basic-Clinical Research Cooperation Fund of Capital Medical University (17JL20), the Beijing Key Laboratory for HIV/AIDS Research (BZ0089), the NSFC-NIH Biomedical collaborative research program (81761128001), and the National Institutes of Health grants (R01 AI091526, AI128864 to WJ).
Acknowledgments
We thank Wei Xia, Yuefang Zhou for patients recruiting, blood and information collecting; Yunxia Ji and Rui Wang for cell counting and viral load detecting, and the individuals participated in our study, for their interest and commitment to the project, which made this work possible.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Supplementary material
The Supplementary Material for this article can be found online at http://journal.frontiersin.org/article/10.3389/fimmu.2017.00991/full#supplementary-material.
Figure S1Correlations between the frequencies of TNaive, TCM, TEM, and TEMRAγδ T cells and neutrophils. γδ T cells can be divided into four functional subsets according to the expression of CD27 and CD45RA. There were no correlations between the frequencies of TNaive(A), TCM(B), TEM(C), and TEMRA(D) γδ T cells and the percentage of neutrophils in all HIV-1-infected patients with RPR− and RPR+. The frequencies of TEM γδ T cells were positively correlated with the percentage of neutrophils in acute and all HIV-1-infected patients with RPR− (
) and RPR+ (
). Correlations were calculated by using Spearman’s rank correlation. P<0.05 was considered to be statistically significant. RPR, rapid plasma reagin.
Correlation between γδ T-cell activation and neutrophils. Two immune activation markers CD38 and HLA-DR were used to evaluate and compare γδ T-cell activation status in both HC and HIV-1-infected patients with RPR− and RPR+. The relationship between γδ T-cell activation and neutrophils was analyzed. There were no correlations between the frequencies of CD38+(A), HLA-DR+(B), and CD38+HLA-DR+(C) γδ T cells and the percentage of neutrophils in all HIV-1-infected patients with RPR− (
) and RPR+ (
). Correlations were calculated by using Spearman’s rank correlation. P<0.05 was considered to be statistically significant. RPR, rapid plasma reagin.
References
1
JansenKSchmidtAJDrewesJBremerVMarcusU. Increased incidence of syphilis in men who have sex with men and risk management strategies, Germany, 2015. Euro Surveill (2016) 21:30382.10.2807/1560-7917.ES.2016.21.43.30382
2
AhnJYBoettigerDKiertiburanakulSMeratiTPHuyBVWongWWet alIncidence of syphilis seroconversion among HIV-infected persons in Asia: results from the TREAT Asia HIV observational database. J Int AIDS Soc (2016) 19:20965.10.7448/IAS.19.1.20965
3
LiuGLuHWangJXiaDSunYMiGet alIncidence of HIV and syphilis among men who have sex with men (MSM) in Beijing: an open cohort study. PLoS One (2015) 10:e0138232.10.1371/journal.pone.0138232
4
ChenYCLiuHYLiCYLeeNYLiCWKoWCet alThe rising trend of sexually transmitted infections among HIV-infected persons: a population-based cohort study in Taiwan, 2000 through 2010. J Acquir Immune Defic Syndr (2015) 68:432–8.10.1097/QAI.0000000000000477
5
BurchellANAllenVGGardnerSLMoravanVTanDHGrewalRet alHigh incidence of diagnosis with syphilis co-infection among men who have sex with men in an HIV cohort in Ontario, Canada. BMC Infect Dis (2015) 15:356.10.1186/s12879-015-1098-2
6
MaoHMaWLuHWangLZhengHZhuYet alHigh incidence of HIV and syphilis among migrant men who have sex with men in Beijing, China: a prospective cohort study. BMJ Open (2014) 4:e005351.10.1136/bmjopen-2014-005351
7
Syphilis on the rise in the USA. Lancet (2011) 378:542.10.1016/S0140-6736(11)61274-9
8
KotsaftiOPaparizosVKourkountiSChatziioannouANicolaidouEKapsimaliVet alEarly syphilis affects markers of HIV infection. Int J STD AIDS (2016) 27:739–45.10.1177/0956462415592326
9
KofoedKGerstoftJMathiesenLRBenfieldT. Syphilis and human immunodeficiency virus (HIV)-1 coinfection: influence on CD4 T-cell count, HIV-1 viral load, and treatment response. Sex Transm Dis (2006) 33:143–8.10.1097/01.olq.0000187262.56820.c0
10
BuchaczKPatelPTaylorMKerndtPRByersRHHolmbergSDet alSyphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS (2004) 18:2075–9.10.1097/00002030-200410210-00012
11
RobertsCPKlausnerJD. Global challenges in human immunodeficiency virus and syphilis coinfection among men who have sex with men. Expert Rev Anti Infect Ther (2016) 14:1037–46.10.1080/14787210.2016.1236683
12
PialouxGVimontSMoulignierAButeuxMAbrahamBBonnardP. Effect of HIV infection on the course of syphilis. AIDS Rev (2008) 10:85–92.
13
LynnWALightmanS. Syphilis and HIV: a dangerous combination. Lancet Infect Dis (2004) 4:456–66.10.1016/S1473-3099(04)01061-8
14
Colomer-LluchMGollahonLSSerra-MorenoR. Anti-HIV factors: targeting each step of HIV’s replication cycle. Curr HIV Res (2016) 14:175–82.10.2174/1570162X14999160224094621
15
SimonVBlochNLandauNR. Intrinsic host restrictions to HIV-1 and mechanisms of viral escape. Nat Immunol (2015) 16:546–53.10.1038/ni.3156
16
VanpouilleCIntroiniAMorrisSRMargolisLDaarESDubeMPet alDistinct cytokine/chemokine network in semen and blood characterize different stages of HIV infection. AIDS (2016) 30:193–201.10.1097/QAD.0000000000000964
17
Santa-MartaMde BritoPMGodinho-SantosAGoncalvesJ. Host factors and HIV-1 replication: clinical evidence and potential therapeutic approaches. Front Immunol (2013) 4:343.10.3389/fimmu.2013.00343
18
AlbinJSHarrisRS. Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics. Expert Rev Mol Med (2010) 12:e4.10.1017/S1462399409001343
19
WangCZhuLGaoZGuanZLuHShiMet alIncreased interleukin-17 in peripheral blood and cerebrospinal fluid of neurosyphilis patients. PLoS Negl Trop Dis (2014) 8:e3004.10.1371/journal.pntd.0003004
20
PastuszczakMJakielaBWielowieyska-SzybinskaDJaworekAKZemanJWojas-PelcA. Elevated cerebrospinal fluid interleukin-17A and interferon-gamma levels in early asymptomatic neurosyphilis. Sex Transm Dis (2013) 40:808–12.10.1097/OLQ.0000000000000024
21
ChienYHMeyerCBonnevilleM. Gammadelta T cells: first line of defense and beyond. Annu Rev Immunol (2014) 32:121–55.10.1146/annurev-immunol-032713-120216
22
MaoYYinSZhangJHuYHuangBCuiLet alA new effect of IL-4 on human gammadelta T cells: promoting regulatory Vdelta1 T cells via IL-10 production and inhibiting function of Vdelta2 T cells. Cell Mol Immunol (2016) 13:217–28.10.1038/cmi.2015.07
23
LiuzziARMcLarenJEPriceDAEberlM. Early innate responses to pathogens: pattern recognition by unconventional human T-cells. Curr Opin Immunol (2015) 36:31–7.10.1016/j.coi.2015.06.002
24
PauzaCDPooniaBLiHCairoCChaudhryS. Gammadelta T cells in HIV disease: past, present, and future. Front Immunol (2015) 5:687.10.3389/fimmu.2014.00687
25
LiHChaudhrySPooniaBShaoYPauzaCD. Depletion and dysfunction of Vgamma2Vdelta2 T cells in HIV disease: mechanisms, impacts and therapeutic implications. Cell Mol Immunol (2013) 10:42–9.10.1038/cmi.2013.13
26
LiZJiaoYHuYCuiLChenDWuHet alDistortion of memory Vdelta2 gammadelta T cells contributes to immune dysfunction in chronic HIV infection. Cell Mol Immunol (2015) 12:604–14.10.1038/cmi.2014.77
27
StaryGKleinIBruggenMCKohlhoferSBrunnerPMSpaziererDet alHost defense mechanisms in secondary syphilitic lesions: a role for IFN-gamma-/IL-17-producing CD8+ T cells?Am J Pathol (2010) 177:2421–32.10.2353/ajpath.2010.100277
28
HuangXLodiSFoxZLiWPhillipsAPorterKet alRate of CD4 decline and HIV-RNA change following HIV seroconversion in men who have sex with men: a comparison between the Beijing PRIMO and CASCADE cohorts. J Acquir Immune Defic Syndr (2013) 62:441–6.10.1097/QAI.0b013e31827f5c9a
29
HubertJBBurgardMDussaixETamaletCDeveauCLe ChenadecJet alNatural history of serum HIV-1 RNA levels in 330 patients with a known date of infection. The SEROCO Study Group. AIDS (2000) 14:123–31.
30
CohenMSGayCLBuschMPHechtFM. The detection of acute HIV infection. J Infect Dis (2010) 202(Suppl 2):S270–7.10.1086/655651
31
FiebigEWWrightDJRawalBDGarrettPESchumacherRTPeddadaLet alDynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS (2003) 17:1871–9.10.1097/00002030-200309050-00005
32
JanierMHegyiVDupinNUnemoMTiplicaGSPotocnikMet al2014 European guideline on the management of syphilis. J Eur Acad Dermatol Venereol (2014) 28:1581–93.10.1111/jdv.12734
33
ChenPSuBZhangTZhuXXiaWFuYet alPerturbations of monocyte subsets and their association with T helper cell differentiation in acute and chronic HIV-1-infected patients. Front Immunol (2017) 8:272.10.3389/fimmu.2017.00272
34
LuXSuBXiaHZhangXLiuZJiYet alLow double-negative CD3+CD4-CD8- T cells are associated with incomplete restoration of CD4+ T cells and higher immune activation in HIV-1 immunological non-responders. Front Immunol (2016) 7:579.10.3389/fimmu.2016.00579
35
OkoyeAAPickerLJ. CD4(+) T-cell depletion in HIV infection: mechanisms of immunological failure. Immunol Rev (2013) 254:54–64.10.1111/imr.12066
36
DouekDCPickerLJKoupRA. T cell dynamics in HIV-1 infection. Annu Rev Immunol (2003) 21:265–304.10.1146/annurev.immunol.21.120601.141053
37
Di MitriDAzevedoRIHensonSMLibriVRiddellNEMacaulayRet alReversible senescence in human CD4+CD45RA+CD27- memory T cells. J Immunol (2011) 187:2093–100.10.4049/jimmunol.1100978
38
CaccamoNLa MendolaCOrlandoVMeravigliaSTodaroMStassiGet alDifferentiation, phenotype, and function of interleukin-17-producing human Vgamma9Vdelta2 T cells. Blood (2011) 118:129–38.10.1182/blood-2011-01-331298
39
RibotJCdeBarrosAPangDJNevesJFPeperzakVRobertsSJet alCD27 is a thymic determinant of the balance between interferon-gamma- and interleukin 17-producing gammadelta T cell subsets. Nat Immunol (2009) 10:427–36.10.1038/ni.1717
40
CuaDJTatoCM. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol (2010) 10:479–89.10.1038/nri2800
41
ShibataKYamadaHHaraHKishiharaKYoshikaiY. Resident Vdelta1+ gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J Immunol (2007) 178:4466–72.10.4049/jimmunol.178.7.4466
42
StarkMAHuoYBurcinTLMorrisMAOlsonTSLeyK. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity (2005) 22:285–94.10.1016/j.immuni.2005.01.011
43
LiZLiWLiNJiaoYChenDCuiLet alGammadelta T cells are involved in acute HIV infection and associated with AIDS progression. PLoS One (2014) 9:e106064.10.1371/journal.pone.0106064
44
SabbioneFGabelloniMLErnstGGoriMSSalamoneGOleastroMet alNeutrophils suppress gammadelta T-cell function. Eur J Immunol (2014) 44:819–30.10.1002/eji.201343664
45
ZhuAHanHZhaoHHuJJiangCXieFet alIncreased frequencies of Th17 and Th22 cells in the peripheral blood of patients with secondary syphilis. FEMS Immunol Med Microbiol (2012) 66:299–306.10.1111/j.1574-695X.2012.01007.x
46
VantouroutPHaydayA. Six-of-the-best: unique contributions of gammadelta T cells to immunology. Nat Rev Immunol (2013) 13:88–100.10.1038/nri3384
47
BonnevilleMO’BrienRLBornWK. Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity. Nat Rev Immunol (2010) 10:467–78.10.1038/nri2781
48
KalyanSChandrasekaranVQuabiusESLindhorstTKKabelitzD. Neutrophil uptake of nitrogen-bisphosphonates leads to the suppression of human peripheral blood gammadelta T cells. Cell Mol Life Sci (2014) 71:2335–46.10.1007/s00018-013-1495-x
49
CoffeltSBKerstenKDoornebalCWWeidenJVrijlandKHauCSet alIL-17-producing gammadelta T cells and neutrophils conspire to promote breast cancer metastasis. Nature (2015) 522:345–8.10.1038/nature14282
50
ZhengNNMcElrathMJSowPSMesherAHawesSESternJet alAssociation between peripheral gammadelta T-cell profile and disease progression in individuals infected with HIV-1 or HIV-2 in West Africa. J Acquir Immune Defic Syndr (2011) 57:92–100.10.1097/QAI.0b013e318215a877
51
ArrollTWCenturion-LaraALukehartSAVan VoorhisWC. T-Cell responses to Treponema pallidum subsp. pallidum antigens during the course of experimental syphilis infection. Infect Immun (1999) 67:4757–63.
52
FayNSLarsonECJamesonJM. Chronic inflammation and gammadelta T cells. Front Immunol (2016) 7:210.10.3389/fimmu.2016.00210
53
DenigerDCMoyesJSCooperLJ. Clinical applications of gamma delta T cells with multivalent immunity. Front Immunol (2014) 5:636.10.3389/fimmu.2014.00636
54
QinGLiuYZhengJXiangZNgIHMalik PeirisJSet alPhenotypic and functional characterization of human gammadelta T-cell subsets in response to influenza A viruses. J Infect Dis (2012) 205:1646–53.10.1093/infdis/jis253
55
UtayNSHuntPW. Role of immune activation in progression to AIDS. Curr Opin HIV AIDS (2016) 11:131–7.10.1097/COH.0000000000000242
56
KelesidisT. The cross-talk between spirochetal lipoproteins and immunity. Front Immunol (2014) 5:310.10.3389/fimmu.2014.00310
57
RadolfJDArndtLLAkinsDRCurettyLLLeviMEShenYet alTreponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages. J Immunol (1995) 154:2866–77.
58
AcetoLKarrerUGrubeCOberholzerRHasseBPresterlEet al[Primary HIV-1 infection in Zurich: 2002-2004]. Praxis (Bern 1994) (2005) 94:1199–205.10.1024/0369-8394.94.32.1199
59
BolzDDSundsbakRSMaYAkiraSKirschningCJZacharyJFet alMyD88 plays a unique role in host defense but not arthritis development in Lyme disease. J Immunol (2004) 173:2003–10.10.4049/jimmunol.173.3.2003
60
BenhniaMRWroblewskiDAkhtarMNPatelRALavezziWGangloffSCet alSignaling through CD14 attenuates the inflammatory response to Borrelia burgdorferi, the agent of Lyme disease. J Immunol (2005) 174:1539–48.10.4049/jimmunol.174.3.1539
61
KalyanSKabelitzD. When neutrophils meet T cells: beginnings of a tumultuous relationship with underappreciated potential. Eur J Immunol (2014) 44:627–33.10.1002/eji.201344195
62
AmatyaNGargAVGaffenSL. IL-17 signaling: the Yin and the Yang. Trends Immunol (2017) 38:310–22.10.1016/j.it.2017.01.006
63
HagenCEKamionekMMcKinseyDSMisdrajiJ. Syphilis presenting as inflammatory tumors of the liver in HIV-positive homosexual men. Am J Surg Pathol (2014) 38:1636–43.10.1097/PAS.0000000000000264
64
Freundt-RevillaJMaioliniACarlsonRBeyerbachMRentmeisterKFlegelTet alTh17-skewed immune response and cluster of differentiation 40 ligand expression in canine steroid-responsive meningitis-arteritis, a large animal model for neutrophilic meningitis. J Neuroinflammation (2017) 14:20.10.1186/s12974-016-0784-3
65
ShilaihMMarzelABraunDLScherrerAUKovariHYoungJet alFactors associated with syphilis incidence in the HIV-infected in the era of highly active antiretrovirals. Medicine (Baltimore) (2017) 96:e5849.10.1097/MD.0000000000005849
66
St LegerAJDesaiJVDrummondRAKugadasAAlmaghrabiFSilverPet alAn ocular commensal protects against corneal infection by driving an interleukin-17 response from mucosal gammadelta T cells. Immunity (2017) 47:148–58.e5.10.1016/j.immuni.2017.06.014
67
KhairallahCDechanet-MervilleJCaponeM. Gammadelta T cell-mediated immunity to cytomegalovirus infection. Front Immunol (2017) 8:105.10.3389/fimmu.2017.00105
68
CouziLPitardVMoreauJFMervillePDechanet-MervilleJ. Direct and indirect effects of cytomegalovirus-induced gammadelta T cells after kidney transplantation. Front Immunol (2015) 6:3.10.3389/fimmu.2015.00003
69
ContiHRPetersonACBraneLHupplerARHernandez-SantosNWhibleyNet alOral-resident natural Th17 cells and gammadelta T cells control opportunistic Candida albicans infections. J Exp Med (2014) 211:2075–84.10.1084/jem.20130877
Summary
Keywords
syphilis, acute/chronic HIV-1 infection, γδ T cells, innate immune response, IL-17
Citation
Li Z, Lu X, Hu Z, Luo Z, Jiang W, Wu H, Gao Y, Yan J, Zhang Q, Song A, Huang X, Mou D, Su B and Zhang T (2017) Syphilis Infection Differentially Regulates the Phenotype and Function of γδ T Cells in HIV-1-Infected Patients Depends on the HIV-1 Disease Stage. Front. Immunol. 8:991. doi: 10.3389/fimmu.2017.00991
Received
14 May 2017
Accepted
03 August 2017
Published
21 August 2017
Volume
8 - 2017
Edited by
Persephone Borrow, University of Oxford, United Kingdom
Reviewed by
Maria Raffaella Zocchi, Scientific Institute San Raffaele, Italy; Paul Urquhart Cameron, University of Melbourne, Australia
Updates
Copyright
© 2017 Li, Lu, Hu, Luo, Jiang, Wu, Gao, Yan, Zhang, Song, Huang, Mou, Su and Zhang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Bin Su, binsu.paris7@hotmail.com; Tong Zhang, zt_doc@163.com
†These authors have contributed equally to this work.
Specialty section: This article was submitted to HIV and AIDS, a section of the journal Frontiers in Immunology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.